Younes, A., Oki, Y., McLaughlin, P., Copeland, A. R., Goy, A., Pro, B., . . . Fayad, L. E. (2012). Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. American Society of Hematology.
Styl cytowania ChicagoYounes, Anas, et al. Phase 2 Study of Rituximab Plus ABVD in Patients With Newly Diagnosed Classical Hodgkin Lymphoma. American Society of Hematology, 2012.
Styl cytowania MLAYounes, Anas, et al. Phase 2 Study of Rituximab Plus ABVD in Patients With Newly Diagnosed Classical Hodgkin Lymphoma. American Society of Hematology, 2012.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..